Literature DB >> 12944653

Cyclo(-Cha-Oxz-D-Val-Thz-Ile-Oxz-D-Val-Thz-) N,N-dimethylacetamide dihydrate: a square form of cyclohexylalanine-incorporated ascidiacyclamide having the strongest cytotoxicity.

Akiko Asano1, Takeshi Yamada, Atsushi Numata, Mitsunobu Doi.   

Abstract

The title compound, 1-cyclohexylmethyl-1-de(1-methylpropyl)ascidiacyclamide N,N-dimethylacetamide dihydrate, C(39)H(56)N(8)O(6)S(2) x C(4)H(9)NO x 2H(2)O, a cyclohexylalanine-incorporated ascidiacyclamide analogue ([Cha]ASC), shows a square form similar to natural ASC. On the other hand, CD (circular dichroism) spectra showed [Cha]ASC to have a folded structure in solution, making it the second known analogue to show a discrepancy between its crystal and solution structures. Moreover, the cytotoxicity of [Cha]ASC (ED(50) = 5.6 micro g ml(-1)) was approximately two times stronger than that of natural ASC or a related phenylalanine-incorporated analogue, viz. cyclo(-Phe-Oxz-D-Val-Thz-Ile-Oxz-D-Val-Thz-) ([Phe]ASC), and was confirmed to be associated with the square form. However, [Phe]ASC was previously shown to be folded in the crystal structure, which suggests that the difference between the aromatic and aliphatic rings affects the molecular folding of the ASC molecule.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944653     DOI: 10.1107/s0108270103014495

Source DB:  PubMed          Journal:  Acta Crystallogr C        ISSN: 0108-2701            Impact factor:   1.172


  3 in total

1.  Thiazole-amino acids: influence of thiazole ring on conformational properties of amino acid residues.

Authors:  Monika Staś; Małgorzata A Broda; Dawid Siodłak
Journal:  Amino Acids       Date:  2021-04-10       Impact factor: 3.520

2.  The desoxazoline asidiacyclamide analogue cyclo(Gly-Thr-D-Val-Thz-Ile-Thr-D-Val-Thz) acetonitrile monosolvate.

Authors:  Akiko Asano; Mitsunobu Doi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-12-10

3.  NMR-based quantitative studies of the conformational equilibrium between their square and folded forms of ascidiacyclamide and its analogues.

Authors:  Akiko Asano; Katsuhiko Minoura; Yuki Kojima; Taishi Yoshii; Ryoya Ito; Takeshi Yamada; Takuma Kato; Mitsunobu Doi
Journal:  RSC Adv       Date:  2020-09-09       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.